2020
DOI: 10.1002/adfm.202006796
|View full text |Cite
|
Sign up to set email alerts
|

Bone‐on‐a‐Chip: Microfluidic Technologies and Microphysiologic Models of Bone Tissue

Abstract: Bone is an active organ that continuously undergoes an orchestrated process of remodeling throughout life. Bone tissue is uniquely capable of adapting to loading, hormonal, and other changes happening in the body, as well as repairing bone that becomes damaged to maintain tissue integrity. On the other hand, diseases such as osteoporosis and metastatic cancers disrupt normal bone homeostasis leading to compromised function. Historically, the ability to investigate processes related to either physiologic or dis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
70
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 54 publications
(72 citation statements)
references
References 186 publications
(195 reference statements)
0
70
0
Order By: Relevance
“…[26] However, the translation of EIS studies of bone formation in vivo to the microfluidic environment, with its attendant advantages in terms of reduced reagent volume and the potential for high-throughput and automated studies, [27] remains relatively limited, in part because "bone on chip" models are a relatively immature field in comparison with microfluidic models of other tissues and organs. [28] Investigations of the deposition of mineral on chip under biomimetic conditions using impedance have so far been limited to measurements at a single frequency and a single timepoint. [29] These measurements do not take full advantage of the benefits of EIS, both in terms of the potential to perform automated time-series measurements due to the noninvasive nature of the technique and in terms of the amount of information that can be obtained from a single measurement by performing a frequency sweep.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[26] However, the translation of EIS studies of bone formation in vivo to the microfluidic environment, with its attendant advantages in terms of reduced reagent volume and the potential for high-throughput and automated studies, [27] remains relatively limited, in part because "bone on chip" models are a relatively immature field in comparison with microfluidic models of other tissues and organs. [28] Investigations of the deposition of mineral on chip under biomimetic conditions using impedance have so far been limited to measurements at a single frequency and a single timepoint. [29] These measurements do not take full advantage of the benefits of EIS, both in terms of the potential to perform automated time-series measurements due to the noninvasive nature of the technique and in terms of the amount of information that can be obtained from a single measurement by performing a frequency sweep.…”
Section: Introductionmentioning
confidence: 99%
“…However, the translation of EIS studies of bone formation in vivo to the microfluidic environment, with its attendant advantages in terms of reduced reagent volume and the potential for high‐throughput and automated studies, [ 27 ] remains relatively limited, in part because “bone on chip” models are a relatively immature field in comparison with microfluidic models of other tissues and organs. [ 28 ]…”
Section: Introductionmentioning
confidence: 99%
“…NP cells, AF cells, neurons and endothelial cells); 2) allow the long-term preservation of mice IVDs; and 3) expose IVD cells to physical stimuli such as shear stresses or electrical impulses. While various OoC models are available for other musculoskeletal tissues (for instance bone-on-chip models as reviewed by Mansoorifar et al (2021)), the application of this technology to the IVD field is still relatively budding and progress will be needed to develop representative IVD models. New mechanically active OoCs can be designed, or existing OoCs developed for other purposes could be repurposed for the replication of IVD loading.…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, the pharmaceutical industries working in the area of osteogenic diseases such as rickets, osteoporosis, osteoarthritis, and orthopedic trauma are highly interested in the development of in vitro bone models. [35] While there are certain in vitro bone models that exist in literature, most of them fail to mimic multiple features. Bone is a mechanoresponsive tissue.…”
Section: Discussionmentioning
confidence: 99%